Walleye Capital
ACHV icon

Walleye Capital’s Achieve Life Sciences ACHV Stock Holding History

Walleye Capital’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-900
Closed -$3.71K – 5363
2023
Q4 		$3.71K Hold
900
– – ﹤0.01% 4684
2023
Q3 		$3.87K Sell
900
-49,100
-98% -$247K ﹤0.01% 4632
2023
Q2 		$260K Sell
50,000
-35,700
-42% -$250K ﹤0.01% 2912
2023
Q1 		$583K Buy
+85,700
New +$407K 0.01% 1586

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Walleye Capital's ACHV Position: Q1 2024 in Review

Walleye Capital sold out of Achieve Life Sciences (ACHV) in Q1 2024, closing a stake of 82,599 shares — an estimated $340K sold.

Walleye Capital first reported a position in ACHV in Q3 2018 and held it in 6 quarters. The position peaked at $493K in Q2 2023. 41 funds tracked by Wall St. Rank hold ACHV as of Q1 2024.

  • Walleye Capital reported no remaining Achieve Life Sciences position as of Q1 2024 after selling out during the quarter.
  • Walleye Capital sold 82,599 Achieve Life Sciences shares in Q1 2024, an estimated $340K.
  • Walleye Capital first reported a position in Achieve Life Sciences in Q3 2018 and held it in 6 quarters.
  • Walleye Capital's Achieve Life Sciences position peaked at $493K in Q2 2023.
  • 41 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2024.

Based on Walleye Capital's 13F filing for Q1 2024, filed 15 May 2024.